← Leaderboards
You-Yang Zhao
University Of Illinois At Chicago
$24,398,532
Attributed
$27,195,811
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,195,811 · 12
By mechanism
R01$23,207,301 · 9
P01$3,589,760 · 2
R56$398,750 · 1
Top collaborators
- Asrar B. Malik5 shared
- Roberto F. Machado4 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Arshad Rahman$8,589,196
- Andrei L Gartel$3,460,217
- Dustin Fraidenburg$1,582,688
- Fabeha Fazal$4,412,309
- Chinnaswamy Tiruppathi$17,495,963
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularLungCellsMediatingEndothelial CellsNovel Therapeutic InterventionBlood VesselsSignal TransductionAnimal ModelInjurySepsisEndotheliumComplexRepairedInflammatoryBaseMortalityPathogenesisLung InjuryProgramsMouse ModelPlayEffective TherapyGenetic
Grant awards (53)
Novel intrinsic endothelial stem cells responsible for lung endothelial regeneration and vascular repair in ARDS$759,133
R01 · FY2025 · HL · contact PI
Negative regulators of endothelial regeneration in aging lungs and ARDS$668,687
R01 · FY2025 · HL · contact PI
Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH$660,077
R01 · FY2025 · HL · contact PI
Novel intrinsic endothelial stem cells responsible for lung endothelial regeneration and vascular repair in ARDS$759,133
R01 · FY2024 · HL · contact PI
Negative regulators of endothelial regeneration in aging lungs and ARDS$655,314
R01 · FY2024 · HL · contact PI
Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH$646,874
R01 · FY2024 · HL · contact PI
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension$618,533
R01 · FY2024 · HL · contact PI
Negative regulators of endothelial regeneration in aging lungs and ARDS$668,687
R01 · FY2023 · HL · contact PI
Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH$660,077
R01 · FY2023 · HL · contact PI
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension$631,156
R01 · FY2023 · HL · contact PI
Novel mechanisms of endothelial Injury in the pathogenesis of ARDS$567,818
R01 · FY2023 · HL · contact PI
Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH$679,977
R01 · FY2022 · HL · contact PI
Negative regulators of endothelial regeneration in aging lungs and ARDS$668,687
R01 · FY2022 · HL · contact PI
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension$631,156
R01 · FY2022 · HL · contact PI
Novel mechanisms of endothelial Injury in the pathogenesis of ARDS$567,820
R01 · FY2022 · HL · contact PI
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension$631,156
R01 · FY2021 · HL · contact PI
Novel mechanisms of endothelial Injury in the pathogenesis of ARDS$567,820
R01 · FY2021 · HL · contact PI
Targeting Smooth Muscle Progenitor Cells for Treatment of Pulmonary Arterial Hypertension$497,250
R01 · FY2021 · HL · contact PI
Novel mechanisms of endothelial Injury in the pathogenesis of ARDS$567,820
R01 · FY2020 · HL · contact PI
Targeting Smooth Muscle Progenitor Cells for Treatment of Pulmonary Arterial Hypertension$497,250
R01 · FY2020 · HL · contact PI
Novel mechanisms of obliterative pulmonary vascular remodeling and sever pulmonary arterial hypertension$520,864
R01 · FY2019 · HL · contact PI
Targeting Smooth Muscle Progenitor Cells for Treatment of Pulmonary Arterial Hypertension$497,250
R01 · FY2019 · HL · contact PI
Role of Notch/Jag1 in Reprogramming Macrophages and Resolving Inflammatory Lung Injury$398,151
P01 · FY2019 · HL · contact PI
Repair mechanisms of sepsis induced endothelial dysfunction and lung injury$638,000
R01 · FY2018 · HL
Novel mechanisms of obliterative pulmonary vascular remodeling and sever pulmonary arterial hypertension$534,114
R01 · FY2018 · HL · contact PI
Targeting Smooth Muscle Progenitor Cells for Treatment of Pulmonary Arterial Hypertension$497,250
R01 · FY2018 · HL · contact PI
Role of Notch/Jag1 in Reprogramming Macrophages and Resolving Inflammatory Lung Injury$392,032
P01 · FY2018 · HL · contact PI
Novel Signalings and Molecular Targets Of Endothelial Regeneration In Aging Lung$374,850
R01 · FY2018 · HL · contact PI
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension$679,575
R01 · FY2017 · HL · contact PI
Repair mechanisms of sepsis induced endothelial dysfunction and lung injury$638,000
R01 · FY2017 · HL
Novel Signalings and Molecular Targets of Endothelial Regeneration in Aging Lung$398,750
R01 · FY2017 · HL · contact PI
Role of Notch/Jag1 in Reprogramming Macrophages and Resolving Inflammatory Lung Injury$398,151
P01 · FY2017 · HL · contact PI
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension$679,575
R01 · FY2016 · HL · contact PI
Repair mechanisms of sepsis induced endothelial dysfunction and lung injury$638,000
R01 · FY2016 · HL · contact PI
Novel Signalings and Molecular Targets of Endothelial Regeneration in Aging Lung$398,750
R01 · FY2016 · HL · contact PI
Role of Notch/Jag1 in Reprogramming Macrophages and Resolving Inflammatory Lung Injury$398,088
P01 · FY2016 · HL · contact PI
Repair mechanisms of sepsis induced endothelial dysfunction and lung injury$628,430
R01 · FY2015 · HL · contact PI
Role of Notch/Jag1 in Reprogramming Macrophages and Resolving Inflammatory Lung Injury$397,902
P01 · FY2015 · HL · contact PI
Novel Signalings and Molecular Targets of Endothelial Regeneration in Aging Lung$392,768
R01 · FY2015 · HL · contact PI
Repair mechanisms of sepsis induced endothelial dysfunction and lung injury$638,000
R01 · FY2014 · HL · contact PI
Novel Signalings and Molecular Targets of Endothelial Regeneration in Aging Lung$398,750
R01 · FY2014 · HL · contact PI
Endothelial Repair following Lung Vasc. Injury Regulated by FoxM1/p-Catenin Signa$318,352
P01 · FY2014 · HL · contact PI
FoxM1 regulates endothelial repair following lung vascular injury$398,750
R56 · FY2013 · HL · contact PI
Endothelial Repair following Lung Vasc. Injury Regulated by FoxM1/p-Catenin Signa$309,256
P01 · FY2013 · HL · contact PI
Endothelial Repair following Lung Vasc. Injury Regulated by FoxM1/p-Catenin Signa$324,849
P01 · FY2012 · HL · contact PI
FoxM1 regulates endothelial repair following lung vascular injury$348,750
R01 · FY2011 · HL · contact PI
Endothelial Repair following Lung Vasc. Injury Regulated by FoxM1/p-Catenin Signa$324,849
P01 · FY2011 · HL · contact PI
FoxM1 regulates endothelial repair following lung vascular injury$348,750
R01 · FY2010 · HL · contact PI
Endothelial Repair following Lung Vasc. Injury Regulated by FoxM1/p-Catenin Signa$328,130
P01 · FY2010 · HL · contact PI
FoxM1 regulates endothelial repair following lung vascular injury$348,750
R01 · FY2009 · HL · contact PI
FoxM1 regulates endothelial repair following lung vascular injury$306,200
R01 · FY2009 · HL · contact PI
FoxM1 regulates endothelial repair following lung vascular injury$348,750
R01 · FY2008 · HL · contact PI
FoxM1 regulates endothelial repair following lung vascular injury$348,750
R01 · FY2007 · HL · contact PI